Cargando…

The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity

Multifactorial mechanisms comprising countless cellular factors and virus-encoded transactivators regulate the transcription of HIV-1 (HIV). Since poly(ADP-ribose) polymerase 1 (PARP-1) regulates numerous genes through its interaction with various transcription factors, inhibition of PARP-1 has surf...

Descripción completa

Detalles Bibliográficos
Autores principales: Rom, Slava, Reichenbach, Nancy L., Dykstra, Holly, Persidsky, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548080/
https://www.ncbi.nlm.nih.gov/pubmed/26379653
http://dx.doi.org/10.3389/fmicb.2015.00878
_version_ 1782387150133657600
author Rom, Slava
Reichenbach, Nancy L.
Dykstra, Holly
Persidsky, Yuri
author_facet Rom, Slava
Reichenbach, Nancy L.
Dykstra, Holly
Persidsky, Yuri
author_sort Rom, Slava
collection PubMed
description Multifactorial mechanisms comprising countless cellular factors and virus-encoded transactivators regulate the transcription of HIV-1 (HIV). Since poly(ADP-ribose) polymerase 1 (PARP-1) regulates numerous genes through its interaction with various transcription factors, inhibition of PARP-1 has surfaced recently as a powerful anti-inflammatory tool. We suggest a novel tactic to diminish HIV replication via PARP-1 inhibition in an in vitro model system, exploiting human primary monocyte-derived macrophages (MDM). PARP-1 inhibition was capable to lessen HIV replication in MDM by 60–80% after 7 days infection. Tat, tumor necrosis factor α (TNFα), and phorbol 12-myristate 13-acetate (PMA) are known triggers of the Long Terminal Repeat (LTR), which can switch virus replication. Tat overexpression in MDM transfected with an LTR reporter plasmid resulted in a 4.2-fold increase in LTR activation; PARP inhibition caused 70% reduction of LTR activity. LTR activity, which increased 3-fold after PMA or TNFα treatment, was reduced by PARP inhibition (by 85–95%). PARP inhibition in MDM exhibited 90% diminution in NFκB activity (known to mediate TNFα- and PMA-induced HIV LTR activation). Cytoskeleton rearrangements are important in effective HIV-1 infection. PARP inactivation reduced actin cytoskeleton rearrangements by affecting Rho GTPase machinery. These discoveries suggest that inactivation of PARP suppresses HIV replication in MDM by via attenuation of LTR activation, NFκB suppression and its effects on the cytoskeleton. PARP appears to be essential for HIV replication and its inhibition may provide an effective approach to management of HIV infection.
format Online
Article
Text
id pubmed-4548080
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-45480802015-09-14 The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity Rom, Slava Reichenbach, Nancy L. Dykstra, Holly Persidsky, Yuri Front Microbiol Microbiology Multifactorial mechanisms comprising countless cellular factors and virus-encoded transactivators regulate the transcription of HIV-1 (HIV). Since poly(ADP-ribose) polymerase 1 (PARP-1) regulates numerous genes through its interaction with various transcription factors, inhibition of PARP-1 has surfaced recently as a powerful anti-inflammatory tool. We suggest a novel tactic to diminish HIV replication via PARP-1 inhibition in an in vitro model system, exploiting human primary monocyte-derived macrophages (MDM). PARP-1 inhibition was capable to lessen HIV replication in MDM by 60–80% after 7 days infection. Tat, tumor necrosis factor α (TNFα), and phorbol 12-myristate 13-acetate (PMA) are known triggers of the Long Terminal Repeat (LTR), which can switch virus replication. Tat overexpression in MDM transfected with an LTR reporter plasmid resulted in a 4.2-fold increase in LTR activation; PARP inhibition caused 70% reduction of LTR activity. LTR activity, which increased 3-fold after PMA or TNFα treatment, was reduced by PARP inhibition (by 85–95%). PARP inhibition in MDM exhibited 90% diminution in NFκB activity (known to mediate TNFα- and PMA-induced HIV LTR activation). Cytoskeleton rearrangements are important in effective HIV-1 infection. PARP inactivation reduced actin cytoskeleton rearrangements by affecting Rho GTPase machinery. These discoveries suggest that inactivation of PARP suppresses HIV replication in MDM by via attenuation of LTR activation, NFκB suppression and its effects on the cytoskeleton. PARP appears to be essential for HIV replication and its inhibition may provide an effective approach to management of HIV infection. Frontiers Media S.A. 2015-08-25 /pmc/articles/PMC4548080/ /pubmed/26379653 http://dx.doi.org/10.3389/fmicb.2015.00878 Text en Copyright © 2015 Rom, Reichenbach, Dykstra and Persidsky. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Rom, Slava
Reichenbach, Nancy L.
Dykstra, Holly
Persidsky, Yuri
The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_full The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_fullStr The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_full_unstemmed The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_short The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity
title_sort dual action of poly(adp-ribose) polymerase -1 (parp-1) inhibition in hiv-1 infection: hiv-1 ltr inhibition and diminution in rho gtpase activity
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548080/
https://www.ncbi.nlm.nih.gov/pubmed/26379653
http://dx.doi.org/10.3389/fmicb.2015.00878
work_keys_str_mv AT romslava thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT reichenbachnancyl thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT dykstraholly thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT persidskyyuri thedualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT romslava dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT reichenbachnancyl dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT dykstraholly dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity
AT persidskyyuri dualactionofpolyadpribosepolymerase1parp1inhibitioninhiv1infectionhiv1ltrinhibitionanddiminutioninrhogtpaseactivity